{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T02:24:17Z","timestamp":1779243857944,"version":"3.51.4"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,11,16]],"date-time":"2016-11-16T00:00:00Z","timestamp":1479254400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nutr J"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s12937-016-0214-5","type":"journal-article","created":{"date-parts":[[2016,11,16]],"date-time":"2016-11-16T09:37:38Z","timestamp":1479289058000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Two ghrelin receptor agonists for adults with malnutrition: a systematic review and meta-analysis"],"prefix":"10.1186","volume":"15","author":[{"given":"Jianhua","family":"Su","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin","family":"Geng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jisheng","family":"Bao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yin","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Menglan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haibin","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6519-5094","authenticated-orcid":false,"given":"Suming","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,11,16]]},"reference":[{"key":"214_CR1","doi-asserted-by":"crossref","DOI":"10.1079\/9780851996486.0000","volume-title":"Scientific criteria for defining malnutrition. Disease related malnutrition: an evidence-based approach to treatment","author":"RGC Stratton","year":"2003","unstructured":"Stratton RGC, Elia M. Scientific criteria for defining malnutrition. Disease related malnutrition: an evidence-based approach to treatment. UK: CABI Publishing; 2003."},{"key":"214_CR2","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1007\/BF02696650","volume":"2","author":"YJ Akashi","year":"2005","unstructured":"Akashi YJ, Springer J, Anker SD. Cachexia in chronic heart failure: prognostic implications and novel therapeutic approaches. Curr Heart Fail Rep. 2005;2:198\u2013203.","journal-title":"Curr Heart Fail Rep"},{"key":"214_CR3","doi-asserted-by":"publisher","first-page":"127","DOI":"10.2169\/internalmedicine.45.1402","volume":"45","author":"N Nagaya","year":"2006","unstructured":"Nagaya N, Kojima M, Kangawa K. Ghrelin, a novel growth hormone-releasing peptide, in the treatment of cardiopulmonary-associated cachexia. Intern Med. 2006;45:127\u201334.","journal-title":"Intern Med"},{"key":"214_CR4","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1038\/sj.ki.5001572","volume":"70","author":"M Bossola","year":"2006","unstructured":"Bossola M, Tazza L, Giungi S, Luciani G. Anorexia in hemodialysis patients: an update. Kidney Int. 2006;70:417\u201322.","journal-title":"Kidney Int"},{"key":"214_CR5","first-page":"199","volume":"19","author":"J Crawford","year":"2016","unstructured":"Crawford J. Clinical results in cachexia therapeutics. Curr Opin Clin Nutr Metab Care. 2016;19:199\u2013204.","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"214_CR6","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1507\/endocrj.K09E-168","volume":"56","author":"M Hotta","year":"2009","unstructured":"Hotta M, Ohwada R, Akamizu T, Shibasaki T, Takano K, Kangawa K. Ghrelin increases hunger and food intake in patients with restricting-type anorexia nervosa: a pilot study. Endocr J. 2009;56:1119\u201328.","journal-title":"Endocr J"},{"key":"214_CR7","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1530\/EJE-07-0768","volume":"158","author":"T Akamizu","year":"2008","unstructured":"Akamizu T, Iwakura H, Ariyasu H, Hosoda H, Murayama T, Yokode M, Teramukai S, Seno H, Chiba T, Noma S, et al. Repeated administration of ghrelin to patients with functional dyspepsia: its effects on food intake and appetite. Eur J Endocrinol. 2008;158:491\u20138.","journal-title":"Eur J Endocrinol"},{"key":"214_CR8","doi-asserted-by":"publisher","first-page":"2363","DOI":"10.1111\/j.1532-5415.2008.02031.x","volume":"56","author":"T Akamizu","year":"2008","unstructured":"Akamizu T, Iwakura H, Ariyasu H, Murayama T, Sumi E, Teramukai S, Goto K, Ohnishi E, Akiyama H, Kawanabe K, et al. Effects of ghrelin treatment on patients undergoing total hip replacement for osteoarthritis: different outcomes from studies in patients with cardiac and pulmonary cachexia. J Am Geriatr Soc. 2008;56:2363\u20135.","journal-title":"J Am Geriatr Soc"},{"key":"214_CR9","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.maturitas.2013.07.013","volume":"76","author":"E Agarwal","year":"2013","unstructured":"Agarwal E, Miller M, Yaxley A, Isenring E. Malnutrition in the elderly: a narrative review. Maturitas. 2013;76:296\u2013302.","journal-title":"Maturitas"},{"key":"214_CR10","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1038\/45230","volume":"402","author":"M Kojima","year":"1999","unstructured":"Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, Kangawa K. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature. 1999;402:656\u201360.","journal-title":"Nature"},{"key":"214_CR11","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/1475-2891-8-25","volume":"8","author":"J Ashitani","year":"2009","unstructured":"Ashitani J, Matsumoto N, Nakazato M. Effect of octanoic acid-rich formula on plasma ghrelin levels in cachectic patients with chronic respiratory disease. Nutr J. 2009;8:25.","journal-title":"Nutr J"},{"key":"214_CR12","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1530\/eje.0.1500447","volume":"150","author":"T Akamizu","year":"2004","unstructured":"Akamizu T, Takaya K, Irako T, Hosoda H, Teramukai S, Matsuyama A, Tada H, Miura K, Shimizu A, Fukushima M, et al. Pharmacokinetics, safety, and endocrine and appetite effects of ghrelin administration in young healthy subjects. Eur J Endocrinol. 2004;150:447\u201355.","journal-title":"Eur J Endocrinol"},{"key":"214_CR13","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1007\/s00520-012-1500-1","volume":"21","author":"JM Garcia","year":"2013","unstructured":"Garcia JM, Friend J, Allen S. Therapeutic potential of anamorelin, a novel, oral ghrelin mimetic, in patients with cancer-related cachexia: a multicenter, randomized, double-blind, crossover, pilot study. Support Care Cancer. 2013;21:129\u201337.","journal-title":"Support Care Cancer"},{"key":"214_CR14","first-page":"320","volume":"83","author":"MG Murphy","year":"1998","unstructured":"Murphy MG, Plunkett LM, Gertz BJ, He W, Wittreich J, Polvino WM, Clemmons DR. MK-677, an orally active growth hormone secretagogue, reverses diet-induced catabolism. J Clin Endocrinol Metab. 1998;83:320\u20135.","journal-title":"J Clin Endocrinol Metab"},{"key":"214_CR15","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1517\/14728214.2011.558502","volume":"16","author":"J Tack","year":"2011","unstructured":"Tack J, Janssen P. Emerging drugs for functional dyspepsia. Expert Opin Emerg Drugs. 2011;16:283\u201392.","journal-title":"Expert Opin Emerg Drugs"},{"key":"214_CR16","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1007\/s11894-015-0430-8","volume":"17","author":"A Shin","year":"2015","unstructured":"Shin A, Wo JM. Therapeutic applications of ghrelin agonists in the treatment of gastroparesis. Curr Gastroenterol Rep. 2015;17:430.","journal-title":"Curr Gastroenterol Rep"},{"key":"214_CR17","doi-asserted-by":"crossref","unstructured":"Lembo A, Camilleri M, McCallum R, Sastre R, Breton C, Spence S, White J, Currie M, Gottesdiener K, Stoner E. Relamorelin Reduces Vomiting Frequency and Severity and Accelerates Gastric Emptying in Adults With Diabetic Gastroparesis. Gastroenterology. 2016.","DOI":"10.1053\/j.gastro.2016.03.038"},{"key":"214_CR18","doi-asserted-by":"publisher","first-page":"1814","DOI":"10.1210\/jc.2006-2160","volume":"92","author":"F Piccoli","year":"2007","unstructured":"Piccoli F, Degen L, MacLean C, Peter S, Baselgia L, Larsen F, Beglinger C, Drewe J. Pharmacokinetics and pharmacodynamic effects of an oral ghrelin agonist in healthy subjects. J Clin Endocrinol Metab. 2007;92:1814\u201320.","journal-title":"J Clin Endocrinol Metab"},{"key":"214_CR19","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1038\/sj.bjc.6604148","volume":"98","author":"F Strasser","year":"2008","unstructured":"Strasser F, Lutz TA, Maeder MT, Thuerlimann B, Bueche D, Tschop M, Kaufmann K, Holst B, Brandle M, von Moos R, et al. Safety, tolerability and pharmacokinetics of intravenous ghrelin for cancer-related anorexia\/cachexia: a randomised, placebo-controlled, double-blind, double-crossover study. Br J Cancer. 2008;98:300\u20138.","journal-title":"Br J Cancer"},{"key":"214_CR20","doi-asserted-by":"publisher","first-page":"e35708","DOI":"10.1371\/journal.pone.0035708","volume":"7","author":"K Miki","year":"2012","unstructured":"Miki K, Maekura R, Nagaya N, Nakazato M, Kimura H, Murakami S, Ohnishi S, Hiraga T, Miki M, Kitada S, et al. Ghrelin treatment of cachectic patients with chronic obstructive pulmonary disease: a multicenter, randomized, double-blind, placebo-controlled trial. PLoS One. 2012;7:e35708.","journal-title":"PLoS One"},{"key":"214_CR21","doi-asserted-by":"publisher","first-page":"4521","DOI":"10.1210\/jc.2004-2537","volume":"90","author":"CW Roux le","year":"2005","unstructured":"le Roux CW, Neary NM, Halsey TJ, Small CJ, Martinez-Isla AM, Ghatei MA, Theodorou NA, Bloom SR. Ghrelin does not stimulate food intake in patients with surgical procedures involving vagotomy. J Clin Endocrinol Metab. 2005;90:4521\u20134.","journal-title":"J Clin Endocrinol Metab"},{"key":"214_CR22","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1038\/ijo.2008.270","volume":"33","author":"MS Huda","year":"2009","unstructured":"Huda MS, Dovey T, Wong SP, English PJ, Halford J, McCulloch P, Cleator J, Martin B, Cashen J, Hayden K, et al. Ghrelin restores \u2018lean-type\u2019 hunger and energy expenditure profiles in morbidly obese subjects but has no effect on postgastrectomy subjects. Int J Obes (Lond). 2009;33:317\u201325.","journal-title":"Int J Obes (Lond)"},{"key":"214_CR23","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1210\/jc.2005-2304","volume":"91","author":"D Miljic","year":"2006","unstructured":"Miljic D, Pekic S, Djurovic M, Doknic M, Milic N, Casanueva FF, Ghatei M, Popovic V. Ghrelin has partial or no effect on appetite, growth hormone, prolactin, and cortisol release in patients with anorexia nervosa. J Clin Endocrinol Metab. 2006;91:1491\u20135.","journal-title":"J Clin Endocrinol Metab"},{"key":"214_CR24","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/S1470-2045(15)00558-6","volume":"17","author":"JS Temel","year":"2016","unstructured":"Temel JS, Abernethy AP, Currow DC, Friend J, Duus EM, Yan Y, Fearon KC. Anamorelin in patients with non-small-cell lung cancer and cachexia (ROMANA 1 and ROMANA 2): results from two randomised, double-blind, phase 3 trials. Lancet Oncol. 2016;17:519\u201331.","journal-title":"Lancet Oncol"},{"key":"214_CR25","doi-asserted-by":"publisher","first-page":"W65","DOI":"10.7326\/0003-4819-151-4-200908180-00136","volume":"151","author":"A Liberati","year":"2009","unstructured":"Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gotzsche PC, Ioannidis JP, Clarke M, Devereaux PJ, Kleijnen J, Moher D. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. Ann Intern Med. 2009;151:W65\u201394.","journal-title":"Ann Intern Med"},{"key":"214_CR26","first-page":"\u115f","volume":"5","author":"JPGS Higgins","year":"2008","unstructured":"Higgins JPGS. Handbook for Systematic Reviews of Interventions. Wiley Online Library. 2008;5:\u115f.","journal-title":"Wiley Online Library"},{"key":"214_CR27","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1002\/sim.1186","volume":"21","author":"JP Higgins","year":"2002","unstructured":"Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21:1539\u201358.","journal-title":"Stat Med"},{"key":"214_CR28","first-page":"719","volume":"22","author":"N Mantel","year":"1959","unstructured":"Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 1959;22:719\u201348.","journal-title":"J Natl Cancer Inst"},{"key":"214_CR29","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","volume":"7","author":"R DerSimonian","year":"1986","unstructured":"DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177\u201388.","journal-title":"Control Clin Trials"},{"key":"214_CR30","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1111\/j.0006-341X.2000.00455.x","volume":"56","author":"S Duval","year":"2000","unstructured":"Duval S, Tweedie R. Trim and fill: A simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics. 2000;56:455\u201363.","journal-title":"Biometrics"},{"key":"214_CR31","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","volume":"315","author":"M Egger","year":"1997","unstructured":"Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629\u201334.","journal-title":"BMJ"},{"key":"214_CR32","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1053\/j.gastro.2009.12.058","volume":"138","author":"S Adachi","year":"2010","unstructured":"Adachi S, Takiguchi S, Okada K, Yamamoto K, Yamasaki M, Miyata H, Nakajima K, Fujiwara Y, Hosoda H, Kangawa K, et al. Effects of ghrelin administration after total gastrectomy: a prospective, randomized, placebo-controlled phase II study. Gastroenterology. 2010;138:1312\u201320.","journal-title":"Gastroenterology"},{"key":"214_CR33","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1038\/ki.2009.114","volume":"76","author":"DR Ashby","year":"2009","unstructured":"Ashby DR, Ford HE, Wynne KJ, Wren AM, Murphy KG, Busbridge M, Brown EA, Taube DH, Ghatei MA, Tam FW, et al. Sustained appetite improvement in malnourished dialysis patients by daily ghrelin treatment. Kidney Int. 2009;76:199\u2013206.","journal-title":"Kidney Int"},{"key":"214_CR34","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/S1470-2045(14)71154-4","volume":"16","author":"JM Garcia","year":"2015","unstructured":"Garcia JM, Boccia RV, Graham CD, Yan Y, Duus EM, Allen S, Friend J. Anamorelin for patients with cancer cachexia: an integrated analysis of two phase 2, randomised, placebo-controlled, double-blind trials. Lancet Oncol. 2015;16:108\u201316.","journal-title":"Lancet Oncol"},{"key":"214_CR35","doi-asserted-by":"publisher","first-page":"4785","DOI":"10.1002\/cncr.27430","volume":"118","author":"Y Hiura","year":"2012","unstructured":"Hiura Y, Takiguchi S, Yamamoto K, Takahashi T, Kurokawa Y, Yamasaki M, Nakajima K, Miyata H, Fujiwara Y, Mori M, et al. Effects of ghrelin administration during chemotherapy with advanced esophageal cancer patients: a prospective, randomized, placebo-controlled phase 2 study. Cancer. 2012;118:4785\u201394.","journal-title":"Cancer"},{"key":"214_CR36","doi-asserted-by":"publisher","first-page":"2832","DOI":"10.1210\/jc.2003-031768","volume":"89","author":"NM Neary","year":"2004","unstructured":"Neary NM, Small CJ, Wren AM, Lee JL, Druce MR, Palmieri C, Frost GS, Ghatei MA, Coombes RC, Bloom SR. Ghrelin increases energy intake in cancer patients with impaired appetite: acute, randomized, placebo-controlled trial. J Clin Endocrinol Metab. 2004;89:2832\u20136.","journal-title":"J Clin Endocrinol Metab"},{"key":"214_CR37","doi-asserted-by":"crossref","unstructured":"Takayama K, Katakami N, Yokoyama T, Atagi S, Yoshimori K, Kagamu H, Saito H, Takiguchi Y, Aoe K, Koyama A, et al. Anamorelin (ONO-7643) in Japanese patients with non-small cell lung cancer and cachexia: results of a randomized phase 2 trial. Support Care Cancer. 2016.","DOI":"10.1007\/s00520-016-3144-z"},{"key":"214_CR38","doi-asserted-by":"publisher","first-page":"2111","DOI":"10.1681\/ASN.2005010039","volume":"16","author":"K Wynne","year":"2005","unstructured":"Wynne K, Giannitsopoulou K, Small CJ, Patterson M, Frost G, Ghatei MA, Brown EA, Bloom SR, Choi P. Subcutaneous ghrelin enhances acute food intake in malnourished patients who receive maintenance peritoneal dialysis: a randomized, placebo-controlled trial. J Am Soc Nephrol. 2005;16:2111\u20138.","journal-title":"J Am Soc Nephrol"},{"key":"214_CR39","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.surg.2009.11.026","volume":"148","author":"K Yamamoto","year":"2010","unstructured":"Yamamoto K, Takiguchi S, Miyata H, Adachi S, Hiura Y, Yamasaki M, Nakajima K, Fujiwara Y, Mori M, Kangawa K, Doki Y. Randomized phase II study of clinical effects of ghrelin after esophagectomy with gastric tube reconstruction. Surgery. 2010;148:31\u20138.","journal-title":"Surgery"},{"key":"214_CR40","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1016\/j.ijcard.2014.10.026","volume":"184","author":"S Haehling von","year":"2015","unstructured":"von Haehling S, Anker SD. Treatment of cachexia: An overview of recent developments. Int J Cardiol. 2015;184:736\u201342.","journal-title":"Int J Cardiol"},{"key":"214_CR41","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1634\/theoncologist.12-5-594","volume":"12","author":"JM Garcia","year":"2007","unstructured":"Garcia JM, Polvino WJ. Effect on body weight and safety of RC-1291, a novel, orally available ghrelin mimetic and growth hormone secretagogue: results of a phase I, randomized, placebo-controlled, multiple-dose study in healthy volunteers. Oncologist. 2007;12:594\u2013600.","journal-title":"Oncologist"},{"key":"214_CR42","doi-asserted-by":"publisher","first-page":"2116","DOI":"10.1053\/j.gastro.2007.03.048","volume":"132","author":"AM Wren","year":"2007","unstructured":"Wren AM, Bloom SR. Gut hormones and appetite control. Gastroenterology. 2007;132:2116\u201330.","journal-title":"Gastroenterology"},{"key":"214_CR43","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1038\/35051587","volume":"409","author":"M Nakazato","year":"2001","unstructured":"Nakazato M, Murakami N, Date Y, Kojima M, Matsuo H, Kangawa K, Matsukura S. A role for ghrelin in the central regulation of feeding. Nature. 2001;409:194\u20138.","journal-title":"Nature"},{"key":"214_CR44","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1038\/35038090","volume":"407","author":"M Tschop","year":"2000","unstructured":"Tschop M, Smiley DL, Heiman ML. Ghrelin induces adiposity in rodents. Nature. 2000;407:908\u201313.","journal-title":"Nature"},{"key":"214_CR45","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1007\/s00702-008-0057-0","volume":"115","author":"V Coiro","year":"2008","unstructured":"Coiro V, Saccani-Jotti G, Rubino P, Manfredi G, Vacca P, Volta E, Chiodera P. Oxytocin inhibits the stimulatory effect of ghrelin on circulating neuropeptide Y levels in humans. J Neural Transm (Vienna). 2008;115:1265\u20137.","journal-title":"J Neural Transm (Vienna)"},{"key":"214_CR46","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1172\/JCI200421134","volume":"114","author":"VD Dixit","year":"2004","unstructured":"Dixit VD, Schaffer EM, Pyle RS, Collins GD, Sakthivel SK, Palaniappan R, Lillard Jr JW, Taub DD. Ghrelin inhibits leptin- and activation-induced proinflammatory cytokine expression by human monocytes and T cells. J Clin Invest. 2004;114:57\u201366.","journal-title":"J Clin Invest"},{"key":"214_CR47","doi-asserted-by":"publisher","first-page":"5992","DOI":"10.1210\/jcem.86.12.8111","volume":"86","author":"AM Wren","year":"2001","unstructured":"Wren AM, Seal LJ, Cohen MA, Brynes AE, Frost GS, Murphy KG, Dhillo WS, Ghatei MA, Bloom SR. Ghrelin enhances appetite and increases food intake in humans. J Clin Endocrinol Metab. 2001;86:5992.","journal-title":"J Clin Endocrinol Metab"},{"key":"214_CR48","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1007\/s13539-013-0124-8","volume":"4","author":"S Haehling von","year":"2013","unstructured":"von Haehling S, Anker SD. Cachexia vs obesity: where is the real unmet clinical need? J Cachexia Sarcopenia Muscle. 2013;4:245\u20136.","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"214_CR49","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/1475-2891-12-6","volume":"12","author":"T Letilovic","year":"2013","unstructured":"Letilovic T, Perkov S, Mestric ZF, Vrhovac R. Differences in routine laboratory parameters related to cachexia between patients with hematological diseases and patients with solid tumors or heart failure - is there only one cachexia? Nutr J. 2013;12:6.","journal-title":"Nutr J"},{"key":"214_CR50","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/S0003-4975(01)02847-8","volume":"72","author":"A Jatoi","year":"2001","unstructured":"Jatoi A, Daly BD, Hughes VA, Dallal GE, Kehayias J, Roubenoff R. Do patients with nonmetastatic non-small cell lung cancer demonstrate altered resting energy expenditure? Ann Thorac Surg. 2001;72:348\u201351.","journal-title":"Ann Thorac Surg"},{"key":"214_CR51","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1177\/0884533612457949","volume":"27","author":"S Tsai","year":"2012","unstructured":"Tsai S. Importance of lean body mass in the oncologic patient. Nutr Clin Pract. 2012;27:593\u20138.","journal-title":"Nutr Clin Pract"},{"key":"214_CR52","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1152\/physrev.00012.2004","volume":"85","author":"M Kojima","year":"2005","unstructured":"Kojima M, Kangawa K. Ghrelin: structure and function. Physiol Rev. 2005;85:495\u2013522.","journal-title":"Physiol Rev"},{"key":"214_CR53","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1016\/j.clnu.2008.06.013","volume":"27","author":"WJ Evans","year":"2008","unstructured":"Evans WJ, Morley JE, Argiles J, Bales C, Baracos V, Guttridge D, Jatoi A, Kalantar-Zadeh K, Lochs H, Mantovani G, et al. Cachexia: a new definition. Clin Nutr. 2008;27:793\u20139.","journal-title":"Clin Nutr"},{"key":"214_CR54","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1200\/JCO.2009.23.2488","volume":"28","author":"DA Galvao","year":"2010","unstructured":"Galvao DA, Taaffe DR, Spry N, Joseph D, Newton RU. Combined resistance and aerobic exercise program reverses muscle loss in men undergoing androgen suppression therapy for prostate cancer without bone metastases: a randomized controlled trial. J Clin Oncol. 2010;28:340\u20137.","journal-title":"J Clin Oncol"},{"key":"214_CR55","doi-asserted-by":"publisher","first-page":"2453","DOI":"10.1517\/14656566.2012.734297","volume":"13","author":"A Maccio","year":"2012","unstructured":"Maccio A, Madeddu C, Mantovani G. Current pharmacotherapy options for cancer anorexia and cachexia. Expert Opin Pharmacother. 2012;13:2453\u201372.","journal-title":"Expert Opin Pharmacother"},{"key":"214_CR56","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1097\/SPC.0000000000000012","volume":"7","author":"S Ali","year":"2013","unstructured":"Ali S, Chen JA, Garcia JM. Clinical development of ghrelin axis-derived molecules for cancer cachexia treatment. Curr Opin Support Palliat Care. 2013;7:368\u201375.","journal-title":"Curr Opin Support Palliat Care"},{"key":"214_CR57","doi-asserted-by":"publisher","first-page":"2409","DOI":"10.1007\/s00520-013-1800-0","volume":"21","author":"R Northrup","year":"2013","unstructured":"Northrup R, Kuroda K, Duus EM, Barnes SR, Cheatham L, Wiley T, Pietra C. Effect of ghrelin and anamorelin (ONO-7643), a selective ghrelin receptor agonist, on tumor growth in a lung cancer mouse xenograft model. Support Care Cancer. 2013;21:2409\u201315.","journal-title":"Support Care Cancer"},{"key":"214_CR58","first-page":"S269","volume":"49","author":"J Temel","year":"2013","unstructured":"Temel J, Bondarde S, Jain M, Allen S, Mann W. Efficacy and safety of anamorelin HCl in NSCLC patients: Results from a randomized, double-blind, placebo-controlled, multicenter phase II study. Eur J Cancer. 2013;49:S269\u201370.","journal-title":"Eur J Cancer"},{"key":"214_CR59","doi-asserted-by":"publisher","first-page":"2044","DOI":"10.1002\/cncr.24917","volume":"116","author":"K Lundholm","year":"2010","unstructured":"Lundholm K, Gunnebo L, Korner U, Iresjo BM, Engstrom C, Hyltander A, Smedh U, Bosaeus I. Effects by daily long term provision of ghrelin to unselected weight-losing cancer patients: a randomized double-blind study. Cancer. 2010;116:2044\u201352.","journal-title":"Cancer"},{"key":"214_CR60","doi-asserted-by":"publisher","first-page":"R393","DOI":"10.1530\/ERC-16-0130","volume":"23","author":"S Sever","year":"2016","unstructured":"Sever S, White DL, Garcia JM. Is there an effect of ghrelin\/ghrelin analogs on cancer? A systematic review. Endocr Relat Cancer. 2016;23:R393\u2013409.","journal-title":"Endocr Relat Cancer"}],"container-title":["Nutrition Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12937-016-0214-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12937-016-0214-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12937-016-0214-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,15]],"date-time":"2019-09-15T12:45:20Z","timestamp":1568551520000},"score":1,"resource":{"primary":{"URL":"http:\/\/nutritionj.biomedcentral.com\/articles\/10.1186\/s12937-016-0214-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11,16]]},"references-count":60,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["214"],"URL":"https:\/\/doi.org\/10.1186\/s12937-016-0214-5","relation":{},"ISSN":["1475-2891"],"issn-type":[{"value":"1475-2891","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,11,16]]},"article-number":"97"}}